Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
65
MDGL Quote, Financials, Valuation and Earnings
Last price:
$348.50
Seasonality move
:
2.77%
Day range:
$327.15 - $357.91
52-week range:
$200.63 - $377.46
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
23.69x
P/B ratio:
10.78x
Volume:
1.3M
Avg. volume:
323.5K
1-year change:
26.03%
Market cap:
$7.7B
Revenue:
$180.1M
EPS (TTM):
-$18.05
Earnings Data
Next earnings date for MDGL
Aug 07
2025
Most recent earnings per share
-$3.32
Beat by $0.47
(May 1/2025)
Consensus Estimate
-$3.79
(May 1/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MDGL Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $180.8M | -- | -- | -$3.45 | -- |
| 08/07/2025 | Q2 | $159.4M | -- | -- | -$3.63 | -- |
| 05/01/2025 | Q1 | $114.2M | $137.3M | -$3.32 | -$3.79 | $0.47 |
| 02/26/2025 | Q4 | $97.8M | $103.3M | -$2.71 | -$4.12 | $1.41 |
| 10/31/2024 | Q3 | $34.4M | $62.2M | -$4.92 | -$6.91 | $1.99 |
| 08/07/2024 | Q2 | $4.4M | $14.6M | -$7.10 | -$7.66 | $0.56 |
| 05/07/2024 | Q1 | -- | -- | -$7.38 | -$6.39 | -$0.99 |
| 02/28/2024 | Q4 | -- | -- | -$5.72 | -$5.34 | -$0.38 |
| 11/06/2023 | Q3 | -- | -- | -$5.34 | -$4.93 | -$0.41 |
| 08/08/2023 | Q2 | -- | -- | -$4.69 | -$4.54 | -$0.15 |
| 05/09/2023 | Q1 | -- | -- | -$4.23 | -$4.78 | $0.55 |
| 02/23/2023 | Q4 | -- | -- | -$4.98 | -$4.61 | -$0.37 |
| 11/03/2022 | Q3 | -- | -- | -$4.75 | -$4.18 | -$0.57 |
| 08/04/2022 | Q2 | -- | -- | -$4.14 | -$3.64 | -$0.50 |
| 05/09/2022 | Q1 | -- | -- | -$3.36 | -$3.54 | $0.18 |
| 02/24/2022 | Q4 | -- | -- | -$3.78 | -$3.91 | $0.13 |
| 11/04/2021 | Q3 | -- | -- | -$3.79 | -$3.85 | $0.06 |
| 08/05/2021 | Q2 | -- | -- | -$3.72 | -$3.54 | -$0.18 |
| 05/06/2021 | Q1 | -- | -- | -$3.32 | -$3.89 | $0.57 |
| 02/25/2021 | Q4 | -- | -- | -$3.82 | -$3.90 | $0.08 |
| 11/05/2020 | Q3 | -- | -- | -$3.75 | -$3.30 | -$0.45 |
| 08/06/2020 | Q2 | -- | -- | -$3.18 | -$2.43 | -$0.75 |
| 05/07/2020 | Q1 | -- | -- | -$2.34 | -$1.95 | -$0.39 |
| 02/26/2020 | Q4 | -- | -- | -$1.80 | -$1.67 | -$0.13 |
| 11/06/2019 | Q3 | -- | -- | -$1.39 | -$1.42 | $0.03 |
| 08/07/2019 | Q2 | -- | -- | -$1.28 | -$1.22 | -$0.06 |
| 05/08/2019 | Q1 | -- | -- | -$0.98 | -$0.97 | -$0.01 |
| 02/27/2019 | Q4 | -- | -- | -$0.76 | -$0.74 | -$0.02 |
| 11/06/2018 | Q3 | -- | -- | -$0.56 | -$0.53 | -$0.03 |
| 08/07/2018 | Q2 | -- | -- | -$0.45 | -$0.62 | $0.17 |
| 04/13/2018 | Q1 | -- | -- | -$0.45 | -$0.77 | $0.32 |
| 12/31/2017 | Q4 | -- | -- | -$0.67 | -$0.70 | $0.03 |
| 11/09/2017 | Q3 | -- | -- | -$0.68 | -$0.79 | $0.11 |
| 08/10/2017 | Q2 | -- | -- | -$0.69 | -$0.60 | -$0.09 |
| 04/03/2017 | Q1 | -- | -- | -$0.50 | -$0.87 | $0.37 |
Madrigal Pharmaceuticals Earnings Questions
-
How Much did Madrigal Pharmaceuticals Generate in Revenue Last Quarter?
Madrigal Pharmaceuticals reported $137.3M worth of top line sales in its most recent quarter.
-
Did Madrigal Pharmaceuticals Beat Earnings Last Quarter?
Madrigal Pharmaceuticals announced earnings per share of -$3.32 which represents a beat of analyst forecast a -$3.79 per share.
-
Is Madrigal Pharmaceuticals Profitable?
Madrigal Pharmaceuticals reported $132.7M that represents $6.01 per share over the last quarter.
-
What is the Analyst Consensus for Madrigal Pharmaceuticals EPS Next Year?
Madrigal Pharmaceuticals's earnings are forecast to decrease from -$21.90 per share to -$23.47 per share next year representing a decrease of -41.97%.
-
When is Madrigal Pharmaceuticals's Earnings Date?
Madrigal Pharmaceuticals's next earnings date is August 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 1.42% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.32% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 8.16% over the past day.
